OOIR: Observatory of International Research

Papers

(The H4-Index of BMC Cancer is 41. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Construction and validation of a gene signature related to bladder urothelial carcinoma based on immune gene analysis	226
Chemotherapy in the treatment of different histological types of appendiceal cancers: a SEER based study	132
Therapeutic and immunomodulatory effects of Bojungikki-tang on cancer: a scoping review	103
Lnc-SELPLG-2:1 enhanced osteosarcoma oncogenesis via hsa-miR-10a-5p and the BTRC cascade	101
Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification	101
Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer	100
Novel model integrating computed tomography-based image markers with genetic markers for discriminating radiation pneumonitis in patients with unresectable stage III non-small cell lung cancer receivi	91
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients	91
Chemotherapy dose per kilogram lean body mass increased dose-limiting toxicity event in male head and neck cancer with taxane and platinum-based induction therapy	83
Low-grade inflammation in survivors of childhood cancer and testicular cancer and its association with hypogonadism and metabolic risk factors	78
Exposure–response analyses of cabozantinib in patients with metastatic renal cell cancer	76
Atovaquone inhibits colorectal cancer metastasis by regulating PDGFRβ/NF-κB signaling pathway	75
Tertiary lymphoid structures associate with improved survival in early oral tongue cancer	68
A metabolome-wide case-control study of african american breast cancer patients	67
Associations between female lung cancer risk and sex steroid hormones: a systematic review and meta-analysis of the worldwide epidemiological evidence on endogenous and exogenous sex steroid hormones	67
System-wide identification of novel de-ubiquitination targets for USP10 in gastric cancer metastasis through multi-omics screening	64
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy with or without nimotuzumab in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study	60
The gene expression profile and cell of origin of canine peripheral T-cell lymphoma	59
Survival benefit of adjuvant TACE for patients with hepatocellular carcinoma and child-pugh B7 or B8 after hepatectomy	56
Effects of neoadjuvant radiochemotherapy for anorectal function in locally advanced rectal cancer patients: a study protocol for a prospective, observational, controlled, multicentre study	54
Association of Radiochemotherapy to Immunotherapy in unresectable locally advanced Oesophageal carciNoma—randomized phase 2 trial ARION UCGI 33/PRODIGE 67: the study protocol	54
Changing patterns of nasopharyngeal carcinoma incidence in Hong Kong: a 30-year analysis and future projections	54
Development and psychometric properties of Health-Promoting Lifestyle Scale in Colorectal Cancer Survivors (HPLS-CRCS): a mixed-method study	53
Accumulating evidence from meta-analyses of prognostic studies on oral cancer: towards biomarker-driven patient selection	53
ESR1 PvuII polymorphism: from risk factor to prognostic and predictive factor of the success of primary systemic therapy in advanced breast cancer	52

IMProving care After inherited Cancer Testing (IMPACT) study: protocol of a randomized trial evaluating the efficacy of two interventions designed to improve cancer risk management and family communic	52
Single-copy Snail upregulation causes partial epithelial-mesenchymal transition in colon cancer cells	51
Functions and clinical significance of KLRG1 in the development of lung adenocarcinoma and immunotherapy	50
Adult breast, lung, pancreatic, upper and lower gastrointestinal cancer patients with hospitalized venous thromboembolism in the national French hospital discharge database	49
Network Evolution Model-based prediction of tumor mutation burden from radiomic-clinical features in endometrial cancers	49
AC010883.5 promotes cell proliferation, invasion, migration, and epithelial-to-mesenchymal transition in cervical cancer by modulating the MAPK signaling pathway	48
Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer	48
Combined inflammation-related biomarkers and clinicopathological features for the prognosis of stage II/III colorectal cancer by machine learning	45
Comparing biweekly single-dose actinomycin D with multiday methotrexate therapy for low-risk gestational trophoblastic neoplasia (FIGO Score 0–4): study protocol for a prospective, multicentre, random	45
Antibiotic use during radical surgery in stage I-III colorectal cancer: correlation with outcomes?	44
Rapid and label-free detection of gastrointestinal stromal tumor via a combination of two-photon microscopy and imaging analysis	43
Baseline C-reactive protein predicts efficacy of the first-line immune checkpoint inhibitors plus chemotherapy in advanced lung squamous cell carcinoma: a retrospective, multicenter study	42
Exploring optimal administration timing of pegylated recombinant human granulocyte colony-stimulating factor for chemotherapy-induced neutropenia in early breast cancer treated with pharmorubicin and	42
Association of oxaliplatin-containing adjuvant duration with post-treatment fall-related injury and fracture in patients with stage III colon cancer: a population-based retrospective cohort study	42
The clinical features and prognosis of patients with mucinous breast carcinoma compared with those with infiltrating ductal carcinoma: a population-based study	41
Results from a real-world study: a novel glycosyltransferase risk score for prognosis, tumor microenvironment phenotypes and immunotherapy in bladder cancer	41
A case-control study of a combination of single nucleotide polymorphisms and clinical parameters to predict clinically relevant toxicity associated with fluoropyrimidine and platinum-based chemotherap	41
Optimal treatment strategies for hepatoid adenocarcinoma of the lung: insights from a comprehensive analysis	41
Predicting biochemical-recurrence-free survival using a three-metabolic-gene risk score model in prostate cancer patients	41